4//SEC Filing
CZEREPAK ELIZABETH 4
Accession 0001012975-17-000719
CIK 0001326190other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 6:36 PM ET
Size
7.8 KB
Accession
0001012975-17-000719
Insider Transaction Report
Form 4
CZEREPAK ELIZABETH
CFO and EVP Corp. Development
Transactions
- Award
Stock Options (option to buy)
2017-09-22+62,500→ 62,500 totalExercise: $2.48From: 2019-03-31Exp: 2027-09-22→ Common Stock, par value $0.0001 (62,500 underlying) - Award
Stock Options (option to buy)
2017-09-22+62,500→ 62,500 totalExercise: $2.48From: 2017-09-22Exp: 2027-09-22→ Common Stock, par value $0.0001 (62,500 underlying)
Footnotes (1)
- [F1]The option becomes exercisable, if at all, on March 31, 2019, in three equal one-third increments if the average daily closing price of Altimmune, Inc.'s common stock on Nasdaq for 10 consecutive trading days between September 22, 2017 and December 31, 2018 is at or above one of three specified thresholds, respectively.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001263500
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 6:36 PM ET
- Size
- 7.8 KB